Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 antibody seroprevalence in industry workers in Split-Dalmatia and Šibenik-Knin County, Croatia

View ORCID ProfileIvan Jerković, View ORCID ProfileToni Ljubić, Željana Bašić, Ivana Kružić, Nenad Kunac, Joško Bezić, Arijana Vuko, Alemka Markotić, Šimun Anđelinović
doi: https://doi.org/10.1101/2020.05.11.20095158
Ivan Jerković
1University Department of Forensic Sciences, University of Split, Split, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ivan Jerković
Toni Ljubić
1University Department of Forensic Sciences, University of Split, Split, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Toni Ljubić
Željana Bašić
1University Department of Forensic Sciences, University of Split, Split, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: zeljana.basic@unist.hr
Ivana Kružić
1University Department of Forensic Sciences, University of Split, Split, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nenad Kunac
2Clinical Department for Pathology, Forensic Medicine and Cytology, University Hospital Center Split, Split, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joško Bezić
2Clinical Department for Pathology, Forensic Medicine and Cytology, University Hospital Center Split, Split, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arijana Vuko
2Clinical Department for Pathology, Forensic Medicine and Cytology, University Hospital Center Split, Split, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alemka Markotić
3Dr Fran Mihaljević University Hospital for Infectious Diseases, Zagreb, Croatia
4Catholic University of Croatia, Zagreb, Croatia
5University of Rijeka School of Medicine, Rijeka, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Šimun Anđelinović
2Clinical Department for Pathology, Forensic Medicine and Cytology, University Hospital Center Split, Split, Croatia
6University of Split, School of Medicine, Split, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

BACKGROUND As a result of global spread, COVID-19 has also affected the Republic of Croatia in the last week of February. Although official data show that the number of newly infected is declining, it is still unknown what proportion of the population has been affected by the disease.

AIM To examine seroprevalence of SARS-CoV-2 antibodies in industry workers population sample.

METHODS From 23 to 28 April 2020, we conducted serological testing for antibodies (IgG and IgM) on 1494 factory employees living in the Split-Dalmatia and Šibenik-Knin County (Croatia). We analysed antibody seroprevalence on the level of the company, county, and separately for employees living at the factory premises with limited mobility during the lockdown measures.

RESULTS In a total sample of tested company employees, we detected antibodies in 1.27% of participants (95% CI 0.77-1.98%). In Split facility 13/1316 (0.99%, 95% CI 0.53-1.68%) of participants were tested positive, of which 13/1079 (1.20%, 95% CI 0.64-2.05%) of those living outside the facility and 0/237 (0%, 95% CI 0-1.26%) of those living inside the facility. In Knin facility, 6/178 (3.37%, 95% CI 1.25-7.19%) participants were tested positive for antibodies. The difference between Split (no mobility restrictions) and Knin, was not statistically significant (χ2 = 3.47, P = 0.062).

CONCLUSIONS The study showed relatively small SARS-CoV-2 antibody seroprevalence in the DIV Group population sample. When the study findings are interpreted on the county levels, they could indicate that most of the counties’ population was not exposed to the virus.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The tests used in this study were purchased by the DIV Group.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data that support the findings of this study are available from the corresponding author, [ŽB], upon reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted May 15, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 antibody seroprevalence in industry workers in Split-Dalmatia and Šibenik-Knin County, Croatia
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 antibody seroprevalence in industry workers in Split-Dalmatia and Šibenik-Knin County, Croatia
Ivan Jerković, Toni Ljubić, Željana Bašić, Ivana Kružić, Nenad Kunac, Joško Bezić, Arijana Vuko, Alemka Markotić, Šimun Anđelinović
medRxiv 2020.05.11.20095158; doi: https://doi.org/10.1101/2020.05.11.20095158
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
SARS-CoV-2 antibody seroprevalence in industry workers in Split-Dalmatia and Šibenik-Knin County, Croatia
Ivan Jerković, Toni Ljubić, Željana Bašić, Ivana Kružić, Nenad Kunac, Joško Bezić, Arijana Vuko, Alemka Markotić, Šimun Anđelinović
medRxiv 2020.05.11.20095158; doi: https://doi.org/10.1101/2020.05.11.20095158

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (50)
  • Cardiovascular Medicine (451)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5258)
  • Forensic Medicine (3)
  • Gastroenterology (195)
  • Genetic and Genomic Medicine (757)
  • Geriatric Medicine (80)
  • Health Economics (213)
  • Health Informatics (698)
  • Health Policy (358)
  • Health Systems and Quality Improvement (223)
  • Hematology (99)
  • HIV/AIDS (163)
  • Infectious Diseases (except HIV/AIDS) (5867)
  • Intensive Care and Critical Care Medicine (361)
  • Medical Education (104)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (764)
  • Nursing (43)
  • Nutrition (130)
  • Obstetrics and Gynecology (142)
  • Occupational and Environmental Health (231)
  • Oncology (479)
  • Ophthalmology (152)
  • Orthopedics (38)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (862)
  • Public and Global Health (2011)
  • Radiology and Imaging (348)
  • Rehabilitation Medicine and Physical Therapy (158)
  • Respiratory Medicine (285)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (76)
  • Surgery (109)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)